EP0782388A4 - Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers - Google Patents
Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizersInfo
- Publication number
- EP0782388A4 EP0782388A4 EP95933899A EP95933899A EP0782388A4 EP 0782388 A4 EP0782388 A4 EP 0782388A4 EP 95933899 A EP95933899 A EP 95933899A EP 95933899 A EP95933899 A EP 95933899A EP 0782388 A4 EP0782388 A4 EP 0782388A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- furocoumarin
- sensitizers
- viral
- photodynamic inactivation
- bacterial blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US343680 | 1982-01-28 | ||
US311125 | 1989-02-15 | ||
US08/311,125 US5516629A (en) | 1990-04-16 | 1994-09-22 | Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins |
US08/343,680 US6251644B1 (en) | 1990-04-16 | 1994-11-22 | Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer |
US08/427,080 US5789601A (en) | 1990-04-16 | 1995-04-21 | Method of inactivation of viral and bacterial blood contaminants |
US427080 | 1995-04-21 | ||
US461626 | 1995-06-05 | ||
US08/461,626 US5869701A (en) | 1990-04-16 | 1995-06-05 | Method of inactivation of viral and bacterial blood contaminants |
PCT/US1995/012069 WO1996008965A1 (en) | 1994-09-22 | 1995-09-21 | Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0782388A1 EP0782388A1 (en) | 1997-07-09 |
EP0782388A4 true EP0782388A4 (en) | 2000-03-08 |
Family
ID=27502002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95933899A Withdrawn EP0782388A4 (en) | 1994-09-22 | 1995-09-21 | Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0782388A4 (en) |
AU (1) | AU691672B2 (en) |
CA (1) | CA2199372A1 (en) |
NO (1) | NO971350L (en) |
WO (1) | WO1996008965A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077659A (en) * | 1990-05-15 | 2000-06-20 | New York Blood Center, Inc. | Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light |
CA2221733A1 (en) * | 1995-06-07 | 1996-12-19 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
DE19853425A1 (en) * | 1998-11-19 | 2000-05-25 | Martin Roecken | Topical composition containing khellin or its derivatives, useful for phototherapy of psoriasis and eczema, has low mitogenic potential |
AUPP751298A0 (en) * | 1998-12-04 | 1999-01-07 | Csl Limited | Inactivation of non-enveloped viruses |
DE10031851B4 (en) * | 2000-07-04 | 2005-10-13 | Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH | Photodynamic treatment and UV-B irradiation of a platelet suspension |
US8580192B2 (en) | 2006-10-31 | 2013-11-12 | Ethicon, Inc. | Sterilization of polymeric materials |
EA201790265A1 (en) | 2014-07-23 | 2017-07-31 | Сирус Корпорейшн | METHODS FOR OBTAINING PLATELET-CONTAINING PRODUCTS |
WO2016057965A1 (en) | 2014-10-10 | 2016-04-14 | Cerus Corporation | Compositions and methods for treating viral hemorrhagic fever |
PT3313418T (en) | 2015-06-26 | 2024-06-06 | Cerus Corp | Cryoprecipitate compositions and methods of preparation thereof |
US10799533B2 (en) | 2015-10-23 | 2020-10-13 | Cerus Corporation | Plasma compositions and methods of use thereof |
MX2018008359A (en) | 2016-01-07 | 2019-01-31 | Cerus Corp | Systems and methods for preparation of platelets. |
CN110573169A (en) | 2017-03-03 | 2019-12-13 | 塞鲁斯公司 | Kits and methods for preparing pathogen inactivated platelet compositions |
WO2019060610A1 (en) | 2017-09-20 | 2019-03-28 | Cerus Corporation | Compositions and methods for pathogen inactivation of platelets |
CA3087253A1 (en) | 2017-12-29 | 2019-07-04 | Cerus Corporation | Systems and methods for treating biological fluids |
EP3986499A2 (en) | 2019-06-22 | 2022-04-27 | Cerus Corporation | Biological fluid treatment systems |
CN114269394A (en) | 2019-06-28 | 2022-04-01 | 塞鲁斯公司 | System and method for implementing a biological fluid treatment device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007952A1 (en) * | 1989-01-10 | 1990-07-26 | Emil Bisaccia | Treatment methods and vaccines |
WO1993014791A2 (en) * | 1992-01-27 | 1993-08-05 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
WO1996039816A1 (en) * | 1995-06-07 | 1996-12-19 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5091385A (en) * | 1988-09-30 | 1992-02-25 | Baylor Research Institute | Pre-activated therapeutic agents derived from photoactive compounds |
-
1995
- 1995-09-21 EP EP95933899A patent/EP0782388A4/en not_active Withdrawn
- 1995-09-21 CA CA002199372A patent/CA2199372A1/en not_active Abandoned
- 1995-09-21 AU AU36385/95A patent/AU691672B2/en not_active Ceased
- 1995-09-21 WO PCT/US1995/012069 patent/WO1996008965A1/en not_active Application Discontinuation
-
1997
- 1997-03-21 NO NO971350A patent/NO971350L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007952A1 (en) * | 1989-01-10 | 1990-07-26 | Emil Bisaccia | Treatment methods and vaccines |
WO1993014791A2 (en) * | 1992-01-27 | 1993-08-05 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
WO1996039816A1 (en) * | 1995-06-07 | 1996-12-19 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
Non-Patent Citations (11)
Title |
---|
BLOOD CELLS (1992), 18(1), 75-89, 1992 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; LYTLE, C. DAVID ET AL: "Antiviral activity of gilvocarcin V plus UVA radiation", XP002126269, retrieved from STN Database accession no. 120:100767 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MATTHEWS, J. L. ET AL: "Inactivation of viruses with photoactive compounds", XP002126272, retrieved from STN Database accession no. 117:22546 CA * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MIOLO, G. ET AL: "Antiretroviral activity of furocoumarins plus UVA light detected by a replication-defective retrovirus", XP002126268, retrieved from STN Database accession no. 122:50251 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; RONTO, GYORGYI ET AL: "Action spectra for photoinduced inactivation of bacteriophage T7 sensitized by 8-methoxypsoralen and angelicin", XP002126270, retrieved from STN Database accession no. 111:170121 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; TOTH, K. ET AL: "Characterization of new furocoumarin derivatives by their dark and light-mediated action on RNA bacteriophage MS2", XP002126271, retrieved from STN Database accession no. 109:207546 * |
J. PHOTOCHEM. PHOTOBIOL., B (1988), 2(2), 209-20 * |
J. PHOTOCHEM. PHOTOBIOL., B (1989), 3(4), 497-507 * |
J. PHOTOCHEM. PHOTOBIOL., B (1994), 26(3), 241-7 * |
PHOTOCHEM. PHOTOBIOL. (1993), 58(6), 818-21 * |
See also references of WO9608965A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0782388A1 (en) | 1997-07-09 |
AU3638595A (en) | 1996-04-09 |
NO971350D0 (en) | 1997-03-21 |
NO971350L (en) | 1997-05-22 |
AU691672B2 (en) | 1998-05-21 |
WO1996008965A1 (en) | 1996-03-28 |
CA2199372A1 (en) | 1996-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA912842B (en) | Method of inactivation of viral and bacterial blood contaminants | |
EP0782388A4 (en) | Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers | |
AU7217794A (en) | Method of inactivation of viral and bacterial blood contaminants | |
AP9400675A0 (en) | Sterilized absorbent core and products made therefrom | |
ZA944488B (en) | System for viral inactivation of blood | |
EP0622063A3 (en) | Disposable absorbent articles and methods of making same. | |
HUP9774641A2 (en) | Gel for treatment of skin diseases and for disinfection of the skin | |
ZA9410000B (en) | Deep bed filter for killing off micro-organisms and inactivating viruses and use thereof | |
IL114331A0 (en) | Medical use of bromelain | |
SG42309A1 (en) | Medical use of enzymes | |
AU7717396A (en) | Inactivation of pathogens using hydroxymethylamines | |
EP0830057A4 (en) | Method of inactivation of viral and bacterial blood contaminants | |
AU584548B2 (en) | Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment | |
IL130160A0 (en) | Inactivation of HIV co-receptors as therapy for HIV infection | |
AU7954691A (en) | Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light | |
AU3816300A (en) | Photodynamic inactivation of viruses in biological fluids | |
AU7103594A (en) | Treatment of neonatal hyperbilirubin with metalloporphyrin | |
AU5627890A (en) | Ozone decontamination of blood and blood products | |
GB2246955B (en) | Destruction of microorganisms | |
AU5136496A (en) | Inactivation of pathogens in blood and/or blood products using formaldehyde | |
AU1565895A (en) | Inactivation of viruses present in blood components using chemically-activated compounds | |
NZ231322A (en) | Treatment of viral and/or bacterial infections | |
NZ233973A (en) | Treatment of viral and/or bacterial infections | |
DK0827751T3 (en) | Medical preparation containing tissue plasminogen activator and nicotinamide | |
AU613747C (en) | Sterilization utilizing UV irradiation and inert gas or zone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970321 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 01N 1/02 A, 7A 01N 43/16 B, 7C 12N 15/00 B, 7A 61K 41/00 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000119 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20001010 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20031219 |